Literature DB >> 16138951

Ultrafiltration in decompensated heart failure.

Brian E Jaski1, David Miller.   

Abstract

Fluid congestion is the hallmark of decompensated heart failure. As heart failure progresses, reduced response to diuretics is common. In these patients, ultrafiltration has been found to alleviate excess volume and improve diuretic sensitivity. Compared with diuretics, ultrafiltration provides a more predictable and safer way to achieve euvolemia with minimal electrolyte abnormalities and neurohormonal activation. The emerging familiarity and ease of use of ultrafiltration suggests that in the future this will be an important therapy for the treatment of acute and chronic volume overload associated with decompensated heart failure.

Entities:  

Mesh:

Year:  2005        PMID: 16138951     DOI: 10.1007/s11897-005-0023-1

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  58 in total

1.  Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure.

Authors:  G Marenzi; G Lauri; M Grazi; E Assanelli; J Campodonico; P Agostoni
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

2.  Guidelines for the diagnosis and treatment of chronic heart failure.

Authors:  W J Remme; K Swedberg
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

3.  The beginning of clinical hemofiltration: a personal account.

Authors:  Lee W Henderson
Journal:  ASAIO J       Date:  2003 Sep-Oct       Impact factor: 2.872

4.  Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.

Authors:  Uri Elkayam; Mohammed W Akhter; Harpreet Singh; Salman Khan; Ahsan Usman
Journal:  Am J Cardiol       Date:  2004-01-15       Impact factor: 2.778

5.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

6.  Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain.

Authors:  Karl T Weber
Journal:  J Am Coll Cardiol       Date:  2004-09-15       Impact factor: 24.094

7.  An experimental method for obtaining an ultrafiltrate of the blood.

Authors:  M R MALINOW; W KORZON
Journal:  J Lab Clin Med       Date:  1947-04

8.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.

Authors:  T P Dormans; J J van Meyel; P G Gerlag; Y Tan; F G Russel; P Smits
Journal:  J Am Coll Cardiol       Date:  1996-08       Impact factor: 24.094

9.  Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors:  W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

Review 10.  Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure.

Authors:  A D Struthers
Journal:  J Card Fail       Date:  1996-03       Impact factor: 5.712

View more
  3 in total

1.  Cardiorenal syndrome: A literature review.

Authors:  Narayan Pokhrel; Najindra Maharjan; Bismita Dhakal; Rohit R Arora
Journal:  Exp Clin Cardiol       Date:  2008

2.  Treating volume overload in acutely decompensated heart failure: established and novel therapeutic approaches.

Authors:  Katerina Koniari; John Parissis; Ioannis Paraskevaidis; Maria Anastasiou-Nana
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-09

3.  Therapeutic options for the management of the cardiorenal syndrome.

Authors:  Katerina Koniari; Marinos Nikolaou; Ioannis Paraskevaidis; John Parissis
Journal:  Int J Nephrol       Date:  2010-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.